Will Trump’s Prescription Drug Deals Really Lower Prices?
Update: 2025-10-23
Description
Facing unprecedented pressure from the Trump administration, some of the world’s top drugmakers promise to cut prices. But experts say the savings might not be what they seem.
Guests:
- Michael Cannon, Director of Health Policy Studies, Cato Institute
- Stacie Dusetzina, Professor of Health Policy, Vanderbilt University
- Darius Lakdawalla, Chief Scientific Officer, USC Schaeffer Center
- Pete Loftus, Reporter, Wall Street Journal
- Ben Rome, Assistant Professor of Medicine, Harvard Medical School
- Leslie Walker, Senior Reporter, Tradeoffs
Learn more and read a full transcript on our website.
Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.
Support this type of journalism today, with a gift.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
